Time-updated Fibroblast Growth Factor 23 Is Predictive for Posttransplant Diabetes Mellitus in Kidney Transplant Recipients.

MLA

van der Vaart, Amarens, et al. “Time-Updated Fibroblast Growth Factor 23 Is Predictive for Posttransplant Diabetes Mellitus in Kidney Transplant Recipients.” Journal of the Endocrine Society, vol. 8, no. 5, May 2024, pp. 1–5. EBSCOhost, https://doi.org/10.1210/jendso/bvae055.

APA

van der Vaart, A., Kremer, D., Niekolaas, T., Bakker, S. J. L., Dijk, P. R. van, & Borst, M. H. de. (2024). Time-updated Fibroblast Growth Factor 23 Is Predictive for Posttransplant Diabetes Mellitus in Kidney Transplant Recipients. Journal of the Endocrine Society, 8(5), 1–5. https://doi.org/10.1210/jendso/bvae055

Chicago

van der Vaart, Amarens, Daan Kremer, Tessa Niekolaas, Stephan J L Bakker, Peter R van Dijk, and Martin H de Borst. 2024. “Time-Updated Fibroblast Growth Factor 23 Is Predictive for Posttransplant Diabetes Mellitus in Kidney Transplant Recipients.” Journal of the Endocrine Society 8 (5): 1–5. doi:10.1210/jendso/bvae055.